Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
ARCHIVED: Amendments to the Food and Drugs Act: Guide to New Authorities (power to require and disclose information, power to order a label change and power to order a recall ) - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 202057
Later capture
ARCHIVED: Amendments to the Food and Drugs Act: Guide to New Authorities (power to require and disclose information, power to order a label change and power to order a recall ) - Canada.ca
Jan 2, 2026
hc-20260101
ID 429103
updated1 sections changed
1 sections changed0 added0 removed+0 / -1 linesChange ratio: 0%
--- +++ @@ -492,5 +492,4 @@ A specified reasonable timeframe for the affected party to respond to the notification should the party want to respond to the notification and make representations (this may vary depending upon the severity and immediacy of the risk that the product presents, e.g., 12 hours, 2 business days, 90 days, etc.); A statement that the Minister reserves the right to extend the timeframe for the therapeutic product authorization holder to take action. Page details-Date modified: 2023-08-31